Pharma IPR Conference 2023: The 12th Annual Pharma Intellectual Property Rights

Share this

Pharma IPR Conference 2023: The 12th Annual Pharma Intellectual Property Rights

The 12th edition of the Pharma IPR Conference organized by Informa Markets will be held from 1-3 March 2023 in Mumbai. This is the only conference in India's pharmaceutical industry that focuses on Intellectual Property. The aim of this conference is to bring together all stakeholders in the pharma sector to discuss and deliberate on the challenges faced by innovators and how they can protect their valuable innovations by effective IP management. 

Registration link: https://www.pharmaipr-india.com/REGISTRATION-DETAILS 

The focus is to create a platform for stakeholders, IP Attorneys, and Counsels from across the globe to discuss deliberate, and share their thoughts on achieving the next phase of growth in the Pharma IPR space. The key features of the conference are: 

  • Case studies and practical sessions on different aspects of Intellectual Property Rights in pharma 

  • Representatives from countries targeted by Indian companies 

  • Enhancing your skills to ensure faster approval of patents for early entry in the newer and emerging markets 

  • Updates and recent developments in patent litigation case laws will be discussed 

  • International experts from renowned law firms 

The keynote speakers of the event are: 

  • Dr. Amar Desai, General Manager - Global IP Zydus Cadila 

  • Dr. B P Singh, Former Chairman In-Charge & Technical Member-Patents Intellectual Property Appellate Board (IPAB) Department for Promotion of Industry and Internal 

  • Dr. Harish Chandran Avaronnan, Head of Intellectual Property India, Novozymes 

  • Dr. Paras Vasanani, Head & Associate Vice President-Business Development 
    Portfolio & Strategy, Kashiv BioSciences LLC 

  • Dr. Vivek Mittal, Global General Counsel, Dr. Reddy's Laboratories 

  • Dr B K Sahu, Sr Regional Manager and Head (IPFC & TISC) National Research Development Corporation (DSIR Enterprise, Ministry of S&T, Govt. of India) 

  • Christopher J. Harnett SHAREHOLDER Maynard's New York 

  • Christopher T. Griffith, Lawyer, Pharmaceuticals, Chemicals and Biotechnology 

  • Edward D. Pergament, Founding Partner, Esq., Pergament & Cepeda LLP 

  • Gautam Bakshi, Head & Patent Counsel Intellectual Property Management 
    Unichem labs 

  • John Cabeca, United States Intellectual Property Counselor for South Asia United States Department of Commerce 

  • Nevin Koshy, Partner and Head IP of Patent – Design - Copyright Department 
    United Trademark & Patent Services 

  • Dr. Patnala Sri Ramachandra Murth, Director, Head - IPR department 
    Neuland Laboratories Limited 

  • Prachi Tiwari, Sr. Director (Head) – IP Fresenius Kabi 

  • Srinivasa Reddy Madduri, Vice President & Head – Global Portfolio, BD & IP, Granules India Limited 

The three days conference will be driven by insightful content and speaker profiles. It will bring together the attendees from big pharma & biopharma companies including heads, VPs, managers, senior managers, executives, and general managers to discuss managing, protecting, enforcing and monetizing intellectual property portfolios. 

Related Post: Global PHT Expo & Summit 2023, An International Conference & Exhibition on Pharma, Healthcare & Technology 

Senior Editor

Senior Editor at PharmaShots. She is curious and very passionate about recent updates and developments in the life sciences industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots.

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions